BioTwin Preventative Health and Decision Support Tools based on Human Virtual Twin derived from biometrics & biomarkers
Biotwin has raised $2.5M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2022.
Biotwin's investors include Investissement Quebec, Campus des Technologies de la Santé/CTS Healthcare.
Biotwin is headquartered in Quebec, Canada.
BioTwin Preventative Health and Decision Support Tools based on Human Virtual Twin derived from biometrics & biomarkers
Biotwin is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biotwin — Funding & Investors." VCBacked, October 11, 2022, https://www.vcbacked.co/company/biotwin. Accessed August 13, 2026.
VCBacked. (2022). Biotwin — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biotwin
{{cite web |title=Biotwin — Funding & Investors |url=https://www.vcbacked.co/company/biotwin |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated